共 15 条
- [1] Efficacy and Safety of Weekly Alendronate Plus Vitamin D3 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized TrialYONSEI MEDICAL JOURNAL, 2014, 55 (03) : 715 - 724Kim, Kwang JoonMin, Yong-KiKoh, Jung-MinChung, Yoon-SokKim, Kyoung MinByun, Dong-WonKim, In JooKim, MikyungKim, Sung-SooMin, Kyung WanHan, Ki OkPark, Hyoung MooShin, Chan SooChoi, Sung HeePark, Jong SukChung, Dong JinMok, Ji OhBaek, Hong SunMoon, Seong-HwanKim, Yong SooLim, Sung-Kil
- [2] Efficacy of fosavance 5600® (once weekly alendronate 70 mg & vitamin D3 5600 iu combination) relative to risedronate 35 mg weekly for the prevention of fractures in postmenopausal osteoporosis:: Results of a mixed-treatment indirect comparison meta-analysisCALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S223 - S224Bergman, G. J. D.Fan, T.Sen, S. S.Jansen, J. P.
- [3] Efficacy and Safety of Weekly Alendronate Plus Vitamin D3 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial (vol 55, pg 715, 2014)YONSEI MEDICAL JOURNAL, 2014, 55 (04) : 1163 - 1163Kim, Kwang JoonMin, Yong-KiKoh, Jung-MinChung, Yoon-SokKim, Kyoung MinByun, Dong-WonKim, In JooKim, MikyungKim, Sung-SooMin, Kyung WanHan, Ki OkPark, Hyoung MooShin, Chan SooChoi, Sung HeePark, Jong SukChung, Dong JinMok, Ji OhBaek, Hong SunMoon, Seong-HwanKim, Yong SooLim, Sung-Kil
- [4] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal womenOSTEOPOROSIS INTERNATIONAL, 2003, 14 : S84 - S85Papadimitropoulos, EABlackhouse, GGoeree, RCoyte, PCJosse, RGAdachi, JDGreenwood, CE
- [5] The cost-effectiveness of calcium and Vitamin D or hormone replacement therapy in the prevention of osteoporotic fractures in Canadian postmenopausal women.JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S279 - S279Papadimitropoulos, E.Goeree, R.Blackhouse, G.Coyte, P. C.Josse, R. G.Adachi, J. D.Greenwood, C. E.
- [6] COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTUREVALUE IN HEALTH, 2019, 22 : S243 - S243Hiligsmann, M.Williams, S.Fitzpatrick, L.Silverman, S.Weiss, R. J.Reginster, J. Y.
- [7] CORRELATIONS BETWEEN 25(OH)D AND BMD CHANGE IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN: SECONDARY ANALYSES OF A 1-YEAR TRIAL OF WEEKLY ALENDRONATE (ALN) PLUS VITAMIN D3 5600 IU VS. STANDARD CAREOSTEOPOROSIS INTERNATIONAL, 2012, 23 : S238 - S239Reginster, Jean-YvesBinkley, NeilBoonen, StevenKiel, Douglas P.Ralston, StuartRoux, ChristianPong, AnnpeyRosenberg, ElizabethSantora, Arthur
- [8] Weekly alendronate plus vitamin D3 5600 IU vs. standard care: Effect on serum 25(OH) vitamin D, bone turnover markers, and BMD in osteoporotic postmenopausal women with vitamin D inadequacy-1-year results of a randomized trialBONE, 2011, 48 : S218 - S218Kiel, D. P.Binkley, N.Boonen, S.Ralston, S.Regnister, J-Y.Roux, C.Chen, L.Rosenberg, E.Santora, A.
- [9] WEEKLY ALENDRONATE PLUS VITAMIN D3 5600 IU VS. STANDARD CARE: EFFECT ON SERUM 25(OH) VITAMIN D, BONE TURNOVER MARKERS, AND BMD IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN WITH VITAMIN D INADEQUACY-1-YEAR RESULTS OF A RANDOMIZED TRIALOSTEOPOROSIS INTERNATIONAL, 2011, 22 : S425 - S425Binkley, NeilKiel, Douglas P.Boonen, StevenRalston, StuartRegnister, Jean-YvesRoux, ChristianChen, LiangRosenberg, ElizabethSantora, Arthur
- [10] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women.JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S384 - S384Papadimitropoulos, EAGoeree, RBlackhouse, GCoyte, PJosse, RGAdachi, JGreenwood, C